Scarica l'app Stockscreener
173.65
1.79%
3.0062
Precedente Chiudi:
$170.64
Aprire:
$168.08
Volume 24 ore:
988.42K
Relative Volume:
0.53
Capitalizzazione di mercato:
$29.48B
Reddito:
$16.30B
Utile/perdita netta:
$1.36B
Rapporto P/E:
22.10
EPS:
7.8573
Flusso di cassa netto:
$2.05B
1 W Prestazione:
+4.88%
1M Prestazione:
-27.94%
6M Prestazione:
-8.00%
1 anno Prestazione:
-6.86%
Intervallo 1D:
$167.12
$174.00
Intervallo di 1 settimana:
$159.67
$174.00
Portata 52W:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
173.70 | 28.96B | 16.30B | 1.36B | 2.05B | 7.8573 |
|
TMO
Thermo Fisher Scientific Inc
|
515.55 | 195.41B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
207.43 | 148.05B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
659.09 | 52.76B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.77 | 34.22B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
317.99 | 31.67B | 3.17B | 642.63M | 516.49M | 10.77 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-11-03 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap - Yahoo Finance
IQVIA Holdings Inc. (NYSE : IQV) entered into a definitive agreement to acquire European Discovery Services Assets from Charles River Laboratories International, Inc. (NYSE - marketscreener.com
IQVIA to acquire drug discovery assets from Charles River Labs By Investing.com - Investing.com Nigeria
Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans - Benzinga
Did AI‑Driven Obesity Research Wins and Strong 2025 Results Just Shift IQVIA's (IQV) Investment Narrative? - simplywall.st
IQVIA to acquire drug discovery assets from Charles River Labs - Investing.com
Charles River raises annual profit view as it sells underperforming assets - marketscreener.com
Iqvia signs agreement to acquire drug discovery assets from Charles River Laboratories, expanding end-to-end drug discovery capabilities - marketscreener.com
Charles River Laboratories Provides Update on Planned Divestitures - Business Wire
IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats - Finviz
HSBC Adjusts Price Target on IQVIA Holdings to $240 From $270, Maintains Buy Rating - marketscreener.com
IQVIA Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
EDENTREE ASSET MANAGEMENT Ltd Buys Shares of 38,800 IQVIA Holdings Inc. $IQV - Defense World
Citigroup Inc. Boosts Stock Holdings in IQVIA Holdings Inc. $IQV - Defense World
Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating - Insider Monkey
IQVIA (NYSE:IQV) Stock Rating Upgraded by Wall Street Zen - MarketBeat
AMG National Trust Bank Invests $3.71 Million in IQVIA Holdings Inc. $IQV - MarketBeat
Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV) - The Globe and Mail
IQVIA Holdings (IQV): Truist Securities Lowers Price Target Whil - GuruFocus
Assessing IQVIA Holdings (IQV) Valuation After DCRI Collaboration And 2026 Growth Guidance - Yahoo Finance
IQVIA Holdings Inc (IQV) Shares Gap Down to $164.41 on Feb 19 - GuruFocus
Truist Securities Cuts IQVIA Price Target to $245 From $290, Maintains Buy Rating - marketscreener.com
IQVIA Stock Already Down 25% This Year: Here’s What Analysts Say - TIKR.com
NEOS Investment Management LLC Grows Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
Is Wall Street Bullish or Bearish on IQVIA Holdings Stock? - Yahoo Finance
Vanguard Group Inc. Sells 185,926 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA to Speak at Citi’s 2026 Unplugged MedTech and Life Sciences Access Day - BioSpace
IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day - PharmiWeb.com
Unlocking IQVIA (IQV) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
CenterBook Partners LP Purchases 21,051 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight - GuruFocus
TD Cowen cuts IQVIA stock price target on AI concerns By Investing.com - Investing.com Canada
TD Cowen cuts IQVIA stock price target on AI concerns - Investing.com Australia
TD Cowen Adjusts Price Target on IQVIA to $174 From $245, Maintains Hold Rating - marketscreener.com
IQVIA HOLDINGS INC. SEC 10-K Report - TradingView
Crestwood Advisors Group LLC Acquires 19,022 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Momentum Shift: How volatile is IQVIA Holdings Inc stock2025 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Eagle Rock Investment Company LLC Increases Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Can IQVIA Holdings Inc. lead its sector in growthSwing Trade & Daily Technical Forecast Reports - mfd.ru
IQVIA Holdings Inc. $IQV Shares Acquired by Coronation Fund Managers Ltd. - MarketBeat
Cibc World Market Inc. Buys 10,658 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Assetmark Inc. Purchases 11,928 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Assessing IQVIA Holdings (IQV) Valuation After Sharp Three Month Share Price Pullback - Sahm
Is IQVIA Holdings Inc. (QTS) stock inflation resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Market Overview: What are Comerica Incorporateds growth levers2025 Major Catalysts & Real-Time Volume Triggers - baoquankhu1.vn
IQVIA Duke Alliance Highlights Obesity Trials And Potential Valuation Upside - Sahm
IQVIA Holdings Inc.: Inside the Data, AI, and Capital Strategy Shaping Its Next Chapter! - Smartkarma
IQVIA Holdings Inc (IQV) Stock Price, Trades & News - GuruFocus
Is the Options Market Predicting a Spike in IQVIA Stock? - Nasdaq
US prescriptions for Novo's Wegovy pill were 38,220 (not '38,909') for week ended Feb 6IQVIA data shared by analyst shows - marketscreener.com
Rhumbline Advisers Sells 25,227 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.78%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):